Brand check

Is Disprin banned in India?

Last checked 19 September 2026

Disprin. Status: Not banned.

Disprin and other single-ingredient aspirin products are not banned in India as of 19 Sep 2026; the only aspirin-related prohibition is the aspirin + ethoheptazine FDC under S.O. 3068(E) of 11 Jun 2026.

Classification
No ban or recall found in official records
Decided by
CDSCO / Ministry of Health and Family Welfare
Reference
No Section 26A notification for aspirin; S.O. 3068(E), 11 Jun 2026, covers aspirin + ethoheptazine only
Latest action
11 June 2026
Last checked
19 September 2026

Enteric-coated aspirin tablets. Photo: Regular strength enteric coated aspirin tablets.jpg by Ragesoss (CC BY-SA 4.0). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.

Primary government sourceTier 1: government primary source

CDSCO: Drugs banned in India (consumer section)

CDSCO / Ministry of Health and Family Welfare · No Section 26A notification for aspirin; S.O. 3068(E), 11 Jun 2026, covers aspirin + ethoheptazine only

View original document

Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.

Key facts

Governing authority
CDSCO, Ministry of Health and Family Welfare
Ban notification
None for aspirin alone
Related FDC ban
Acetylsalicylic acid + ethoheptazine, S.O. 3068(E), 11 Jun 2026
Marketer
Reckitt (Disprin); USV (Ecosprin)
Children
Aspirin is avoided in children with viral fever (Reye's syndrome), a clinical caution, not a ban

Where the claim comes from

The 16-FDC notification of 11 June 2026 began with 'acetylsalicylic acid + ethoheptazine' as S.O. 3068(E). Lists that shortened this to 'aspirin banned' produced a spike in 'is Disprin banned' and 'is aspirin banned in India' searches. The long-standing advice against aspirin in children with viral fevers is sometimes also described as a ban.

Disprin is a soluble aspirin tablet and one of the oldest painkiller brands in India. Aspirin is also used in low doses to prevent heart attacks and strokes under brands such as Ecosprin. None of this is banned.

The trigger for the question was the Health Ministry's notification of 11 June 2026 prohibiting 16 fixed-dose combinations. The first entry, S.O. 3068(E), is acetylsalicylic acid with ethoheptazine, an old analgesic pairing that had little modern use. Because "acetylsalicylic acid" is the chemical name for aspirin, summaries of the list read "aspirin combination banned" and then, in shorter form, "aspirin banned". The order applies only to that combination.

Single-ingredient aspirin has never been notified under Section 26A. It appears in the National List of Essential Medicines for cardiovascular use, and Disprin, Ecosprin and their generics are licensed.

A separate point often folded into the question: doctors avoid aspirin in children and teenagers with viral illnesses because of the risk of Reye's syndrome. That is a prescribing caution found in the product label, not a regulatory prohibition.

If you take aspirin daily on a doctor's advice, the June 2026 order changes nothing. If you have an old pain tablet whose label mentions ethoheptazine, ask your pharmacist about disposal.

What this means for you

Disprin and Ecosprin are unaffected

Both are single-ingredient aspirin and remain on sale.

Check old pain combinations

A product listing ethoheptazine alongside aspirin should no longer be dispensed after June 2026.

Low-dose aspirin for the heart continues

Do not change a cardiologist-prescribed aspirin dose on the basis of a headline.

This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.

Batches flagged in CDSCO alerts

Products whose name matches this brand or molecule in CDSCO monthly NSQ alerts. A flagged batch is a single batch; the company's response, where reported, is noted on the page above.

Product Batch Manufacturer Reason declared NSQ Tested by Alert
Clopidogrel & Aspirin Tablets IP P0825176TMfg 2025-08 · Exp 2027-07 Pharmaroots HealthcareHimachal Pradesh Dissolution, Free Salicylic Acid, Content of Clopidogrel (38.20%) and Aspirin (21.8%)Dissolution Drugs Testing Laboratory, Chennai-06State lab Jul 2026
Clopidogrel & Aspirin Tablets TSF-C2763Mfg 2024-10 · Exp 2026-09 Spen Formulations Pvt. Ltd DescriptionDescription Drugs Testing Laboratory, Chennai-06State lab Jul 2026
Clopidogrel & Aspirin Tablets GT31923CMfg 2026-02 · Exp 2028-01 J.M.LaboratoriesHimachal Pradesh Free salicylic Acid (12.01%) and Content of Aspirin (77.13%)Other Drugs Testing Laboratory, Chennai-06State lab Jul 2026
ASPIRIN TABLET IP 75MG 240968Mfg 2024-09 · Exp 2027-08 MODI ANTIBIOTICS Plot No-28 G.I.D.C. Estate Odhav Ahmedabad 382415Gujarat l]five (5) intact strips often (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2. The content of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling FDAL, MumbaiState lab Jul 2026
ASPIRIN TABLET IP 75MG 250168Mfg 2025-01 · Exp 2027-12 MODI ANTIBIOTICS Plot No-28 G.I.D.C. Estate Odhav Ahmedabad 382415Gujarat 1. five (5) intact strips of ten (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2 The co tent of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling FDAL, MumbaiState lab Jul 2026
ASPIRIN GASTRO- RESISTANT TABLETS I.P. 75 MG CBT-0254Mfg 2025-10 · Exp 2027-09 Crossasia Biotech Pvt. Ltd. Survery No. 488 A.B. Road Girwai industrial Area Beldarpura Gwalior 474002 (M.P) Description test for Salicylic Acid Assay for Aspirin and test for DissolutionAssay RDTL. Bellary KarnatakaState lab Jul 2026
Rosuvastatin, Aspirin and Clopidogrel Capsules SIBP25509Mfg 2025-08 · Exp 2027-07 Bioaltus Pharmaceuticals Pvt. LtdSikkim The sample does not conform to the claim with respect to Assay of Rosuvastatin and Aspirin.Assay DTL JaipurState lab May 2026
Clopidogrel and Aspirin Capsules ND260242Mfg 2026-01 · Exp 2027-12 Nanoceut Therapeutics Pvt. LtdPuducherry Free Salicylic acidOther DTL, Chennai-06State lab May 2026
Aspirin Gastro-resistant and Atorvastatin Capsules IP (75mg/10mg) AAC5053Mfg 2025-07 · Exp 2027-06 Vivimed Labs LimitedTelangana The sample does not conforms to I.P.2022 with respect to the Test for Related substances for Aspirin and Atorvastatin.Related substances CDTL, MumbaiCDSCO lab May 2026
Aspirin Gastro-resistant Tablets IP 75 mg ANET1273Mfg 2024-10 · Exp 2026-09 Unicure India LimitedUttar Pradesh Dissolution, Salicylic Acid and Assay as per IPAssay DTL KonniState lab May 2026
Aspirin Gastro-resistant Tablets IP 75 mg ANET1283Mfg 2024-10 · Exp 2026-09 Unicure India LtdUttar Pradesh Dissolution, Salicylic Acid and AssayAssay DTL ThrissurState lab May 2026
Aspirin Gastro-Resistant Tablets IP 75mg ANET1243Mfg 2024-05 · Exp 2026-04 Unicure India LtdUttar Pradesh The Sample fails the test 'Descriptive Part, Dissolution, Salicylic Acid and Assay as per IPAssay DTL ThiruvananthapuramState lab Apr 2026
Aspirin Gastro-Resistant Tablets IP 150 mg ASB07J24Mfg 2024-10 · Exp 2026-09 Bajaj Healthcare LtdGujarat Test for DissolutionDissolution RDTL, Bellary, KarnatakaState lab Mar 2026
Dispersible Aspirin Tablets T-6705Mfg 2025-07 · Exp 2027-06 Jackson Laboratories Pvt.Ltd. 22-24Punjab The sample is not of standard quality for the reason stated under Description of the tablets.Description RDTL, GuwahatiCDSCO lab Feb 2026
Atorvastatin, Aspirin & Clopidogrel Capsules s ADH24148AMfg 2024-10 · Exp 2026-09 Astonea Labs Private LimitedHaryana Test free Salycylic AcidOther MaharashtraState lab Feb 2026
Aspirin Gastro-resistant Tablets IP 75 mg. ANET1295Mfg 2024-12 · Exp 2026-11 Unicure India Ltd. C-21Uttar Pradesh The sample does not comply as per I.P. 2022 with respect to the test for Dissolution in Acid stage for Aspirin.Dissolution RDTL, GuwahatiCDSCO lab Feb 2026
Aspirin Gastro-resistant Tablets IP 75 mg. ANET1295Mfg 2024-12 · Exp 2026-11 Unicure India LtdUttar Pradesh The sample does not conform to I.P.w.r.t. the tests for Dissolution in Acid Stage for Aspirin.Dissolution RDTL, GuwahatiState lab Feb 2026
Aspirin Gastro-Resistant Tablets IP 150 mg ASB02B25Mfg 2025-02 · Exp 2027-01 Bajaj Healthcare Ltd. R.S. No. 1818 Rough Surface on Tablets DescriptionDescription FDTL,UttarakhandState lab Feb 2026
Aspirin Gastro Resistant Tablets IP 75mg ANET 1269Mfg 2024-10 · Exp 2026-09 Unicure India LtdUttar Pradesh Sample fails the test Dissolution' as per IP as specified in the Laboratory ProtocolDissolution DTL ThiruvananthapuramState lab Feb 2026
Clopidogrel & Aspirin Tablets IP GT250518Mfg 2025-03 · Exp 2027-02 Theon Pharmaceuticals Ltd. Vill. Saini MajraHimachal Pradesh The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only.Description CDTL-HyderabadCDSCO lab Dec 2025
Showing 20 of 40 records

Official sources and primary records